Hyundai Motor Group Governance Reform: Not Hyundai Mobis, But a Hidden Real Protagonist / KOSDAQ Bull Market: Now These Stocks Will Soar

Hyundai Motor Group Governance Reform… Not Hyundai Mobis, There's a Hidden Real Protagonist / KOSDAQ Bull Market.. Now 'These Stocks' Will Soar | Director Lee Young-hoon
Watch on YouTube ↗  |  May 24, 2026 at 23:30  |  22:50  |  815 Money Talk (815머니톡)
Speakers
Lee Young-hoon — Director

Summary

Director Lee Young-hoon discusses investment opportunities beyond semiconductors, focusing on Hyundai Motor Group governance reform, Korean shipbuilding, and biotech. He also shares a cautious index outlook, expecting a sideways market through mid-2025. The conversation covers circular shareholding unwinding, re-rating triggers, and tactical rebound plays.

  • Lee remains bullish on Hyundai Motor Group, citing governance restructuring and humanoid robotics value.
  • He highlights strong fundamentals and valuation re-rating potential in Korean shipbuilding stocks.
  • Biotech is viewed as a tactical rebound candidate after a severe selloff, with a preference for cash-rich platform companies.
  • The speaker expects the KOSPI to trade sideways until around August 2025, with top signals appearing in mid-May.
  • He discusses the stock price suppression prevention law as a catalyst for low-PBR stocks but does not name specific plays.
  • Lee reiterates he is holding Samsung Electronics and Hyundai Motor Group stocks long-term.
Trade Ideas
Lee Young-hoon Director 0:51
Bullish on Hyundai Motor Group
The speaker is positive on Hyundai Motor Group, citing governance reform (circular shareholding unwinding) and the high value of its humanoid robotics business. He believes these factors will drive revaluation and continues to hold Hyundai Motor Group shares.
Lee Young-hoon Director 4:58
Bullish on Korean shipbuilding
The speaker is bullish on the Korean shipbuilding sector, citing strong profit growth (Hyundai Heavy Industries 100% YoY), favorable FX rates, delivery of high-margin vessels, ongoing order momentum from LNG and US military demand, and a valuation discount vs. Japanese shipbuilders (30% gap) that could narrow as special-purpose ship (e.g., naval) share increases.
Tactical biotech rebound play
The speaker sees a tactical rebound opportunity in the Korean biotech sector after a sharp 50%+ decline, noting that such drawdowns typically retrace 40%. However, he expects only a temporary gap-filling bounce rather than a full reversal, and advises focusing on companies with sufficient cash (3 years of operating + clinical costs) and a validated platform technology.
Up Next

This 815 Money Talk (815머니톡) video, published May 24, 2026, features Lee Young-hoon discussing 005380.KS, 329180.KS, Hyundai Mipo Dockyard, Korea Shipbuilding & Offshore Engineering, Korean biotech sector. 3 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Lee Young-hoon  · Tickers: 005380.KS, 329180.KS, Hyundai Mipo Dockyard, Korea Shipbuilding & Offshore Engineering, Korean biotech sector